Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients.
about
Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis PatientsPotential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysisRole of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis.Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold.Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis.Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.Predictors of acquired perforating dermatosis in uremic patients on hemodialysis: a case-control study.Skin Autofluorescence, as a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque PsoriasisRole of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
P2860
Q35232132-27EBF9CA-6CDB-4680-8CC6-6FC8E5AD2C4BQ36420791-133E795B-D7F0-4996-BE35-BDA0878CB2FCQ36987459-ABE85204-D4AB-4F55-96CB-DD11F4CDE3D9Q37406686-0B1A3065-0914-47E9-A853-EE4874EEA1F2Q38006722-83B2C891-EECF-4C48-BD1A-A63D1D299FACQ42204098-B414F7B2-B8B1-462F-A544-4BD9EA8D104CQ42333890-8565BBC0-CAB1-46C2-8A6E-990CFCE4684DQ48338398-5D6F51F9-C009-4EBD-B074-E6510E652F24Q52673327-7B60A0B7-0D57-420A-A115-407D3C42BFF4Q55504665-5092CBFB-8091-4C5A-817A-65CA2C5F840FQ58549759-56FD74B5-CCFD-42E9-9291-FAFD71A4FE21Q58551068-E11E4AB9-BD4D-44CF-B783-A792D5979950
P2860
Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Tissue level of advanced glyca ...... els in haemodialysis patients.
@en
Tissue level of advanced glyca ...... els in haemodialysis patients.
@nl
type
label
Tissue level of advanced glyca ...... els in haemodialysis patients.
@en
Tissue level of advanced glyca ...... els in haemodialysis patients.
@nl
prefLabel
Tissue level of advanced glyca ...... els in haemodialysis patients.
@en
Tissue level of advanced glyca ...... els in haemodialysis patients.
@nl
P2093
P2860
P1433
P1476
Tissue level of advanced glyca ...... els in haemodialysis patients.
@en
P2093
Kazuko Sakai
Kei Fukami
Makio Nagano
Masahiro Tanaka
Seiji Ueda
Seiya Okuda
Sho-Ichi Yamagishi
Takafumi Matsumoto
Takuma Hazama
Yusuke Kaida
P2860
P304
P356
10.1111/J.1440-1797.2010.01419.X
P577
2011-03-01T00:00:00Z